explore -WSS

explore

author：explore 2025-09-27 19:21:25 - browse：82463

Sarepta - Cambridge -AP — Kristoffer Tripplaar/Sipa via AP

To hear Sarepta CEO Doug Ingram tell it, the results Monday afternoon from a large trial of its gene therapy for Duchenne muscular dystrophy marked a clear medical breakthrough. “A massive win,” he told investors, that could lead to its approval for all patients with the fatal muscle-wasting disease regardless of age.

And yet the rest of the Duchenne community was more cautious in its enthusiasm. The study — the most rigorous test to date of a technology 30 years in the making — had technically failed, as so many had before it.

“It’s extremely frustrating,” said John Brandsema, a pediatric neurologist at Children’s Hospital of Philadelphia who worked on the study. “When you spend decades trying to bring therapies into the clinic for something so severe and just keep missing over and over again.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： The stock market has soared this year, but will it last? Experts weigh in

explore

WSS

Changes to biosimilar regulatory framework must prioritize patients

Ukraine and a new approach to mental health in war

Judge denies Trump's request for new trial in E. Jean Carroll case

Senators: Long

Are infertility treatments 'essential' during the Covid

Judge denies Trump's request for new trial in E. Jean Carroll case

explore

explore

focus

Apple is now the first public company to be valued at $3 trillion

Intarcia’s device

23andMe had bad news about my health. I wish a person had delivered it

Biotech lab space demand falls sharply

United colonoscopy coverage change 'may cost lives,' doctors say

Delta passengers in Vegas fall sick while waiting on flight in triple

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Lasker Awards 2023: Winners in biomedical research

Malaria cases in Florida and Texas: Here’s what you need to know

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

explore

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

Judge denies Trump's request for new trial in E. Jean Carroll case

Hormonal contraceptives don’t actually treat endometriosis

Drug for rare kidney disease narrowly misses mark in clinical trial

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

hotspot

explore

explore

entertainment